Treatment of Retinoblastoma in 2015: Agreement and Disagreement
The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this report collectively represent their management strategies with an emphasis on areas of agreement and disagreement. Ophthalmic artery chemosurg...
Saved in:
Published in | JAMA ophthalmology Vol. 133; no. 11; p. 1341 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.11.2015
|
Subjects | |
Online Access | Get more information |
ISSN | 2168-6173 |
DOI | 10.1001/jamaophthalmol.2015.3108 |
Cover
Loading…
Abstract | The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this report collectively represent their management strategies with an emphasis on areas of agreement and disagreement. Ophthalmic artery chemosurgery and intravitreous chemotherapy have completely replaced external beam radiotherapy, reduced the use of systemic chemotherapy, and diminished enucleations by 90% without evidence of compromising patient survival. |
---|---|
AbstractList | The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this report collectively represent their management strategies with an emphasis on areas of agreement and disagreement. Ophthalmic artery chemosurgery and intravitreous chemotherapy have completely replaced external beam radiotherapy, reduced the use of systemic chemotherapy, and diminished enucleations by 90% without evidence of compromising patient survival. |
Author | Shields, Carol L Chantada, Guillermo L Munier, Francis L Abramson, David H |
Author_xml | – sequence: 1 givenname: David H surname: Abramson fullname: Abramson, David H organization: Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Ophthalmology, Weill-Cornell Medical Center, New York, New York – sequence: 2 givenname: Carol L surname: Shields fullname: Shields, Carol L organization: Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania – sequence: 3 givenname: Francis L surname: Munier fullname: Munier, Francis L organization: Jules-Gonin Eye Hospital, Faculté de Biologie et Médecine de Lausanne, Lausanne, Switzerland – sequence: 4 givenname: Guillermo L surname: Chantada fullname: Chantada, Guillermo L organization: Research Institute, Hospital J.P. Garrahan, Buenos Aires, Argentina |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26378747$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tqwzAUREVpadI0v1D0A3bvlWRL7qaE9AmBQknX4dqSGgdLMra76N_3mdkMDIcDc8FOY4qOMY6QIwBeHyhQ6vfTnrqQulwAFrlEMCdsLrA0WYlazthyHA_wHQOgZHHOZqKU2mil5-x2OziagosTT56_uqmNqe5onFIg3kb-Y7zhq_fBuV-IouV37UjH4ZKdeepGt_zvBXt7uN-un7LNy-PzerXJSJZ6yjQotABaWU_COiW9MOhsXRa1AtVUCgx6rGzRNAhOVUXjPAEagTV5r1As2NWft_-og7O7fmgDDZ-74xPxBV4wTqA |
CitedBy_id | crossref_primary_10_1016_j_oftal_2017_10_010 crossref_primary_10_1177_1591019917738962 crossref_primary_10_1200_JCO_19_01096 crossref_primary_10_3389_fonc_2022_848877 crossref_primary_10_1167_iovs_64_15_31 crossref_primary_10_3390_antibiotics11050561 crossref_primary_10_1002_iub_1886 crossref_primary_10_1002_kjm2_12523 crossref_primary_10_1515_med_2021_0343 crossref_primary_10_1007_s10792_021_01759_4 crossref_primary_10_1136_bjophthalmol_2017_310294 crossref_primary_10_1016_j_jtos_2020_11_006 crossref_primary_10_1159_000515142 crossref_primary_10_1038_s43018_020_00119_y crossref_primary_10_3892_ijmm_2020_4547 crossref_primary_10_1126_scitranslmed_aat9321 crossref_primary_10_1002_pbc_28882 crossref_primary_10_1007_s13258_021_01043_w crossref_primary_10_1155_2022_2470890 crossref_primary_10_1371_journal_pone_0160094 crossref_primary_10_3389_fimmu_2023_1097456 crossref_primary_10_4103_tjo_TJO_D_24_00107 crossref_primary_10_1136_bjophthalmol_2016_309298 crossref_primary_10_4103_joco_joco_323_21 crossref_primary_10_3892_mmr_2017_7396 crossref_primary_10_1016_j_jfo_2022_06_018 crossref_primary_10_1016_j_preteyeres_2019_05_005 crossref_primary_10_3389_fmed_2022_855661 crossref_primary_10_3390_jcm11216254 crossref_primary_10_1016_j_jaapos_2016_07_230 crossref_primary_10_18632_aging_103075 crossref_primary_10_3390_cancers13092216 crossref_primary_10_1007_s12033_021_00443_3 crossref_primary_10_1016_j_jconrel_2017_08_018 crossref_primary_10_1186_s40942_017_0093_8 crossref_primary_10_2147_OPTH_S398488 crossref_primary_10_1016_j_addr_2023_115006 crossref_primary_10_3390_cancers12082304 crossref_primary_10_1007_s12031_017_1017_7 crossref_primary_10_1097_IAE_0000000000001962 crossref_primary_10_1002_jcp_27812 crossref_primary_10_1038_s41433_022_01980_0 crossref_primary_10_1111_1440_1681_13263 crossref_primary_10_1136_neurintsurg_2019_015597 crossref_primary_10_1016_j_jaapos_2020_12_006 crossref_primary_10_1016_j_preteyeres_2020_100848 crossref_primary_10_1039_D2BM01005D crossref_primary_10_3389_fmed_2021_675703 crossref_primary_10_3390_bioengineering9110671 crossref_primary_10_1016_j_oftal_2018_05_003 crossref_primary_10_1038_srep35264 crossref_primary_10_1136_bjophthalmol_2016_309710 crossref_primary_10_1001_jamaophthalmol_2024_4859 crossref_primary_10_4103_2347_5625_207737 crossref_primary_10_1167_tvst_10_11_10 crossref_primary_10_1001_jama_2024_21396 crossref_primary_10_1371_journal_pone_0151343 crossref_primary_10_1007_s40135_017_0138_z crossref_primary_10_1016_j_oftale_2018_01_002 crossref_primary_10_1159_000491432 crossref_primary_10_3928_23258160_20191211_06 crossref_primary_10_1016_j_canlet_2016_06_012 crossref_primary_10_4103_ijo_IJO_642_19 crossref_primary_10_1038_s41388_017_0050_x crossref_primary_10_4103_ijo_IJO_576_20 crossref_primary_10_3389_fmed_2022_1015301 crossref_primary_10_1016_j_xops_2021_100042 crossref_primary_10_3390_cancers13081862 crossref_primary_10_1038_s41388_020_1372_7 crossref_primary_10_3389_fonc_2024_1372548 crossref_primary_10_1016_j_clp_2020_12_001 crossref_primary_10_1016_j_oret_2024_11_005 crossref_primary_10_1177_11206721231155671 crossref_primary_10_1002_14651858_CD012366_pub2 crossref_primary_10_1007_s00112_017_0364_3 crossref_primary_10_1097_IAE_0000000000002315 crossref_primary_10_4143_crt_2021_1537 crossref_primary_10_1002_pbc_26270 crossref_primary_10_1097_APO_0000000000000360 crossref_primary_10_1038_s41433_021_01845_y crossref_primary_10_1167_iovs_63_9_20 crossref_primary_10_1038_s41420_021_00622_w crossref_primary_10_1186_s12885_020_07314_1 crossref_primary_10_1080_13816810_2017_1393826 crossref_primary_10_1007_s00717_021_00514_5 crossref_primary_10_1177_2474126416677898 crossref_primary_10_1016_j_jbc_2025_108199 crossref_primary_10_1158_1078_0432_CCR_24_0221 crossref_primary_10_1371_journal_pone_0197052 crossref_primary_10_1177_107327481602300203 crossref_primary_10_1080_01676830_2017_1423358 crossref_primary_10_3390_cancers13081876 crossref_primary_10_1002_pbc_28963 crossref_primary_10_1007_s10384_024_01067_1 crossref_primary_10_1007_s00717_023_00550_3 crossref_primary_10_1016_j_jaapos_2023_08_013 crossref_primary_10_1016_j_ophtha_2017_01_048 crossref_primary_10_1007_s12272_018_1094_3 crossref_primary_10_1111_aos_14759 crossref_primary_10_1016_j_ijrobp_2018_12_004 crossref_primary_10_1016_j_ophtha_2020_09_021 crossref_primary_10_1016_j_jaapos_2022_11_014 crossref_primary_10_1016_j_nic_2023_05_011 crossref_primary_10_1016_j_oret_2017_03_013 crossref_primary_10_1097_MD_0000000000012676 crossref_primary_10_1097_IIO_0000000000000266 crossref_primary_10_1002_pbc_31044 crossref_primary_10_1016_j_heliyon_2024_e27653 crossref_primary_10_3390_ijms20051077 crossref_primary_10_1136_neurintsurg_2016_012758 crossref_primary_10_1002_cnr2_1702 crossref_primary_10_1002_cnr2_1949 crossref_primary_10_1097_MPH_0000000000000968 crossref_primary_10_2147_CMAR_S268380 crossref_primary_10_3174_ajnr_A6590 crossref_primary_10_1016_j_oftale_2018_05_014 crossref_primary_10_1016_j_bbrc_2020_03_083 crossref_primary_10_12677_ACM_2024_141266 crossref_primary_10_1136_bjophthalmol_2019_315209 crossref_primary_10_1097_IAE_0000000000001382 crossref_primary_10_1007_s40135_017_0123_6 crossref_primary_10_1097_IIO_0000000000000151 crossref_primary_10_1093_jnci_djy227 crossref_primary_10_1016_j_biopha_2021_111371 crossref_primary_10_1097_APO_0000000000000172 crossref_primary_10_1016_j_bbrc_2021_07_099 crossref_primary_10_1055_a_2237_2943 crossref_primary_10_1186_s40942_018_0124_0 crossref_primary_10_1038_s41598_019_56623_4 crossref_primary_10_1111_aos_14222 crossref_primary_10_1016_j_ijpharm_2020_119824 crossref_primary_10_1080_10717544_2020_1730522 crossref_primary_10_1002_pbc_27959 crossref_primary_10_22608_APO_201778 crossref_primary_10_1371_journal_pone_0197081 crossref_primary_10_1002_cam4_5406 crossref_primary_10_21682_2311_1267_2021_8_1_50_56 crossref_primary_10_1167_iovs_18_25346 crossref_primary_10_4103_JNSM_JNSM_58_20 crossref_primary_10_1002_pbc_26908 crossref_primary_10_3390_children9121939 crossref_primary_10_1542_neo_22_7_e423 crossref_primary_10_1007_s10792_020_01472_8 crossref_primary_10_1080_13816810_2018_1443343 crossref_primary_10_1093_neuros_nyaa142 crossref_primary_10_3389_fgene_2022_864473 crossref_primary_10_3928_23258160_20180129_04 crossref_primary_10_2147_OTT_S370878 crossref_primary_10_1136_bjophthalmol_2017_310624 crossref_primary_10_1002_pbc_26193 crossref_primary_10_3928_01913913_20170201_03 crossref_primary_10_1016_j_colsurfb_2016_07_001 crossref_primary_10_1136_bjophthalmol_2020_317934 crossref_primary_10_14348_molcells_2022_2014 crossref_primary_10_1080_13816810_2016_1244695 crossref_primary_10_1167_iovs_61_6_41 crossref_primary_10_3238_arztebl_2018_0106 crossref_primary_10_1186_s12886_021_02170_4 crossref_primary_10_18632_oncotarget_14487 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1001/jamaophthalmol.2015.3108 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2168-6173 |
ExternalDocumentID | 26378747 |
Genre | Multicenter Study Journal Article Review |
GroupedDBID | 0R~ 4.4 53G AAWTL ABJNI ACGFS ACNCT ACPRK ADBBV AENEX AFOSN AHMBA ALMA_UNASSIGNED_HOLDINGS AMJDE ANMPU BCGUY BRYMA C45 CGR CUY CVF EBD EBS ECM EIF EJD EMOBN EX3 H13 NPM OB3 OBH OGROG OHH OVD PQQKQ RAJ SV3 TEORI WOW |
ID | FETCH-LOGICAL-a367t-7041d0074dfa2de43f281edb65b404c94081f19d5cc10e495cefa01821baff412 |
IngestDate | Thu Jan 02 22:19:58 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a367t-7041d0074dfa2de43f281edb65b404c94081f19d5cc10e495cefa01821baff412 |
PMID | 26378747 |
ParticipantIDs | pubmed_primary_26378747 |
PublicationCentury | 2000 |
PublicationDate | 2015-Nov |
PublicationDateYYYYMMDD | 2015-11-01 |
PublicationDate_xml | – month: 11 year: 2015 text: 2015-Nov |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | JAMA ophthalmology |
PublicationTitleAlternate | JAMA Ophthalmol |
PublicationYear | 2015 |
SSID | ssj0000800435 |
Score | 2.5547512 |
SecondaryResourceType | review_article |
Snippet | The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 1341 |
SubjectTerms | Antineoplastic Agents - administration & dosage Brachytherapy Cryotherapy Eye Enucleation Humans Infusions, Intra-Arterial Intravitreal Injections Laser Coagulation Ophthalmic Artery Retinal Neoplasms - pathology Retinal Neoplasms - therapy Retinoblastoma - pathology Retinoblastoma - therapy |
Title | Treatment of Retinoblastoma in 2015: Agreement and Disagreement |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26378747 |
Volume | 133 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA6rgngR32_JwdtSadqk23oR8YmopxX2tiRNgivbdsF68dc7SdN2V1ZRL2XJsH3N18k3wzwQOglUkDLYeD2meM-jsaBeInrUM-hKhZJmkzHZFk_R3TO9H7BBp_MxXV1SitP0Y25dyX-0CmugV1Ml-wfNNieFBfgN-oUjaBiOv9NxkyVuW4qUo7wQwIbLIuMmjgG7LrOBP_CpVZNMfjV64_XCDDUF89stJi_lCx9nM8H2C_CoM1eZZXPg24oGM0p7LN-a1JHuQ6vBfFTBwc3uaEWmoqHk0tLW23dbjJgVTuwCEIS5Sjy7f1hDFZAoNqWG4YxVrfpb1PAhU0bS9JCba73bqQHt05rsO3YKJDSe_gu8vElmtRpEIdicqmvnz9IvfbVr0QJaAA_DjEx1cZ5Xx6OBSLrUr7pN1by7Mt2k3Zm-eCaWofTX0KpzLfBFhZN11FH5Blp-dMkTm-i8gQsuNJ6FCx7l2FzsDDdgwQAWPA2WLfR8c92_vPPc_AyPh1Gv9Ho-JdJwRKl5IBUNdRATJUXEBPVpmlCgg5okkqUp8RV4yqnS3AeHkwiuNSXBNlrMi1ztIhzQKNVJ7EsmKZWhFJQQlfgiiSjxQxHuoZ3q0YeTqknKsH4p-99KDtBKC6dDtKThq1RHQPFKcWy18Qnu8E5x |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+of+Retinoblastoma+in+2015%3A+Agreement+and+Disagreement&rft.jtitle=JAMA+ophthalmology&rft.au=Abramson%2C+David+H&rft.au=Shields%2C+Carol+L&rft.au=Munier%2C+Francis+L&rft.au=Chantada%2C+Guillermo+L&rft.date=2015-11-01&rft.eissn=2168-6173&rft.volume=133&rft.issue=11&rft.spage=1341&rft_id=info:doi/10.1001%2Fjamaophthalmol.2015.3108&rft_id=info%3Apmid%2F26378747&rft_id=info%3Apmid%2F26378747&rft.externalDocID=26378747 |